课题基金 / 基金详情

PIP2脂筏调控F-actin"踏车"促进肝癌细胞侵袭性伪足形成的机制研究

批准号:
82103651
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
黄登
学科分类:
肿瘤复发与转移
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
黄登

项目摘要

结项摘要

相似基金

相关文献

中文摘要
侵袭性伪足的形成在肝癌侵袭转移中发挥关键作用,F-actin细胞骨架重塑是侵袭性伪足形成的主要驱动力,而脂筏调控的F-actin有效延长是促进伪足形成的关键环节,但具体机制未明。课题组前期发现:磷脂酰肌醇-4,5-二磷酸(PIP2)作为脂筏的主要成分,可使结合在肌动蛋白丝(F-actin)正极的戴帽蛋白α1亚基(CAPZA1)脱落;HSP27以其磷酸化的形式穿梭于PIP2脂筏和F-actin负极之间,且在肝癌中高表达,与肝癌的侵袭转移潜能呈正相关。因此,我们推测:PIP2脂筏可从正负极两端同时调控F-actin的重塑,使其突破踏车现象,实现有效延长——其不仅可通过调控F-actin正极不断聚合延长以促进肝癌细胞膜凸起形成侵袭性伪足,而且还可通过抑制F-actin负极解聚以维持伪足内肌动蛋白细胞骨架的稳定。拟在临床标本、细胞及动物模型上验证该假说,旨在为肝癌侵袭转移提供新的标志物和干预靶点。
英文摘要
The formation of invadopodia plays a key role in the invasion and metastasis of hepatocellular carcinoma (HCC). The remodeling of actin cytoskeleton is the main driving force for the formation of invadopodia, and the effective prolongation of F-actin regulated by lipid raft is the key steps to promote the invadopodia formation, but the specific mechanism remains unclear. We found that in Pre-Experiments: Phosphoinositol-4, 5-diphosphate (PIP2), as the main component of lipid raft, can bind to CAPZA1 to "uncapping" and promote F-actin prolongation; HSP27 could travel between PIP2 lipid raft and F-actin pointed end in its phosphorylation form, which is highly expressed in HCC, and positively correlated with the invasion and metastasis of HCC. Therefore, we speculate that: The PIP2 lipid raft regulates the remodeling of F-actin from both barded and pointed ends, facilitating F-actin to break the tread-milling and achieve effective prolongation -- PIP2 lipid raft not only promotes the formation of invadopodia by regulating the continuous polymerization of the barded end of F-actin, but also maintains the stability of the actin cytoskeleton inside the invadopodia by inhibiting the depolymerization of the pointed end of F-actin. This hypothesis is intended to be tested in clinical specimens, cells and animal models in order to provide new markers and intervention targets for blocking the invasion and metastasis of liver cancer.
在肝癌的侵袭性转移过程中,侵袭性伪足的形成扮演了至关重要的角色。F-actin细胞骨架的重塑是这一过程的主要推动力,而脂筏调控的F-actin有效延长是促进伪足形成的关键环节。尽管如此,其具体机制尚不明确。我们课题组在前期研究中发现,磷脂酰肌醇-4,5-二磷酸(PIP2)作为脂筏的主要成分,能够促使结合在肌动蛋白丝(F-actin)正极的戴帽蛋白α1亚基(CAPZA1)脱落。此外,HSP27在磷酸化形式下,能够在PIP2脂筏和F-actin负极之间穿梭,并且在肝癌中表现出高表达,与肝癌的侵袭转移潜能呈正相关。在本项目中,我们进一步探讨了PIP2与肝细胞癌(HCC)的病理特性及患者预后的关系,深入研究了PIP2调控HSP27转移至细胞核周及HSP27在核周发挥抑制F-actin负极解聚的分子机制,并在体内外验证了Neomycin靶向PIP2抑制HCC的作用。通过本项目的研究,我们进一步阐明了PIP2水平升高可促进HCC的恶性进展;详细阐明了PIP2从正负极两个方向同时调控F-actin重塑的分子机制:一方面,通过调控CAPZA1从F-actin正极脱落促进F-actin正极延长;另一方面,通过激活p38MAPK/HSP27/cofilin途径抑制F-actin负极的解聚。并在体内外实验中证实Neomycin可通过靶向PIP2抑制HCC的侵袭转移。该项目为抑制HCC侵袭转移提供了新的干预靶点——PIP2,并认为Neomycin靶向PIP2在抑制HCC侵袭转移治疗中具有较大潜力,值得进一步深入研究。
国内基金
海外基金